Phibro Animal Health Corporation (PAHC)

Number of days of payables

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Payables turnover 6.49 6.18 7.59 8.31 8.25 8.44 7.91 8.80 9.20 8.95 8.40 7.59 6.87 7.03 7.50 8.70 8.22 8.55 8.46 8.68
Number of days of payables days 56.28 59.02 48.07 43.93 44.26 43.22 46.15 41.48 39.66 40.79 43.46 48.10 53.12 51.92 48.66 41.97 44.40 42.70 43.15 42.05

June 30, 2025 calculation

Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 6.49
= 56.28

The analysis of Phibro Animal Health Corporation's days of payables over the specified periods reveals notable fluctuations throughout the observed timeframe. Starting from 42.05 days as of September 30, 2020, the number of payable days increased slightly over the subsequent quarters, reaching a peak of 53.12 days on June 30, 2022. This upward trend indicates a trend toward longer credit terms extended by the company to its suppliers during this period.

Subsequently, there was a decline observed whereby the days of payables decreased to approximately 39.66 days by June 30, 2023. This suggests an improvement in payment efficiency or more prompt settling of liabilities during this timeframe. However, in the following quarters, the figure again experienced fluctuations: slightly rising to about 41.48 days by September 30, 2023, and then increasing further to 46.15 days by December 31, 2023.

The data for the first quarter of 2024 shows a minor decrease to 43.22 days, with a slight uptick to 44.26 days in June 2024, and a marginal decline back to 43.93 days as of September 30, 2024. Nevertheless, the trend reverses markedly in the subsequent period, with the days of payables escalating sharply to 48.07 days by December 31, 2024. The most significant increase occurs in the first quarter of 2025, where the metric jumps to 59.02 days, followed by a slight decrease to 56.28 days in the second quarter of 2025.

Overall, the pattern demonstrates periods of both extension and contraction in the company's payment practices. The rising trend observed toward the end of the analyzed period, especially the substantial increase in the first quarter of 2025, suggests a deliberate elongation of payment cycles, which could be attributed to strategic financial management, liquidity considerations, or negotiation dynamics with suppliers. Conversely, the shorter payable periods observed at various points reflect periods of improved payment efficiencies.